← Leaderboards
Elias Sayour
University Of Florida
$8,823,629
Attributed
$8,823,629
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2016–25$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,298,633 · 3
FDA$2,524,996 · 1
By mechanism
R01$5,414,166 · 2
R37$2,618,523 · 1
K08$790,940 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Mark A Atkinson$38,540,675
- Clayton E Mathews$19,414,489
- David A Fedele$4,060,728
- Carlos M Rinaldi-Ramos$5,052,225
- Brian Lim Hoh$21,293,492
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMediatingImmunotherapeutic AgentSafetyTumorNanoparticleToxic EffectFormulationMessenger RnaPathway InteractionsTumor-DerivedVaccinesHourBiopsyImmune SystemImmunologicsDendritic CellsImmunotherapyImmunoregulationClinical TrialsImmuneChronicAnimalsCohort
Grant awards (17)
Overcoming metastatic spread of osteosarcoma with RNA loaded nanoparticles$1,200,245
R01 · FY2025 · CA · contact PI
A phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 08/21/2020$645,379
R01 · FY2025 · FD · contact PI
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas$632,873
R37 · FY2025 · CA · contact PI
A phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 08/21/2020$617,119
R01 · FY2024 · FD · contact PI
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas$601,230
R37 · FY2024 · CA · contact PI
Overcoming metastatic spread of osteosarcoma with RNA loaded nanoparticles$597,571
R01 · FY2024 · CA · contact PI
Overcoming metastatic spread of osteosarcoma with RNA loaded nanoparticles$531,320
R01 · FY2023 · CA · contact PI
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas$434,992
R37 · FY2023 · CA · contact PI
A phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 08/21/2020$1,262,498
R01 · FY2022 · FD · contact PI
Overcoming metastatic spread of osteosarcoma with RNA loaded nanoparticles$560,034
R01 · FY2022 · CA · contact PI
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas$476,622
R37 · FY2022 · CA · contact PI
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas$472,806
R37 · FY2021 · CA · contact PI
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma$158,188
K08 · FY2020 · CA · contact PI
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma$158,188
K08 · FY2019 · CA · contact PI
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma$158,188
K08 · FY2018 · CA · contact PI
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma$158,188
K08 · FY2017 · CA · contact PI
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma$158,188
K08 · FY2016 · CA · contact PI